Dain Rauscher is prominent on this one. We noted the increase in activity for Pacific Growth recently.......
Tuesday March 14, 8:27 am Eastern Time
Company Press Release
LJL BioSystems Files Registration Statement for
Common Stock Offering of 2.5 Million Shares
SUNNYVALE, Calif.--(BUSINESS WIRE)--March 14, 2000--LJL BioSystems, Inc. (Nasdaq:LJLB - news) today
announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed offering of up
to 2.5 million shares of its Common Stock, excluding 375,000 shares issuable upon exercise of the underwriters' overallotment
option. All of the shares offered will be sold by the Company. FleetBoston Robertson Stephens and Chase H&Q, a division of
Chase Securities Inc., will act as co-lead underwriters of the offering with Dain Rauscher Wessels acting as co-manager.
(snip)
Adams, Harkness & Hill..........
Tuesday March 14, 8:19 am Eastern Time
Company Press Release
SOURCE: Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Completes Offering of
2,750,000 Shares of Common Stock
TARRYTOWN, N.Y., March 14 /PRNewswire/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS - news) today announced
the completion of an offering of 2,750,000 shares of common stock at a price of $72.75 per share. Chase H&Q, Deutsche
Banc Alex. Brown, Warburg Dillon Read LLC, and Adams, Harkness & Hill, Inc. served as underwriters for the offering.
Emisphere received approximately $188 million after expenses. Proceeds from the offering will be used to fund development of
preclinical stage programs, to fund the Phase III clinical program for oral heparin, and for general corporate purposes. After the
offering, Emisphere has approximately 17.3 million shares outstanding.
(snip)
$190 million. The world has changed. The companies that have filled in behind the valuations will sit at the bargaining table with new found strength. They'll need the big-science companies that have not "filled" as partners going forward.
A new plateau for the sector. Congrats, all! |
